# Varana Capital

> Varana Capital is a VC fund backing Autonomous Vehicles. See 32 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 32
- Last investment: Oct 2025
- Lead investor: 28%
- Fund size: $20M
- Last fund: Feb 2024
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/5078394
- Website: https://www.varanacapital.com

Varana Capital is an investment firm.

## Contacts

5 contacts available for Varana Capital. Shizune tracks 1 team members at Varana Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/varana-capital?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2.3M–$6M |
| Series A | $17M–$35M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Autonomous Vehicles | 5 | 16% |
| Artificial Intelligence | 5 | 16% |
| Automotive | 4 | 13% |
| Software | 3 | 9% |
| Medical Device | 3 | 9% |

43 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 7 | 22% |
| Seed | 3 | 9% |
| Series A | 3 | 9% |
| Post-IPO Equity | 3 | 9% |
| Series B | 2 | 6% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 10 | 31% |
| United States | 5 | 16% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ezra Gardner | Co-Founder | 1 | https://shizune.co/investors/profile/ezra-gardner |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CustoMED | CustoMed transforms surgical planning and execution. It does this by converting medical imaging into 3D visualizations, planning procedures, and producing customized 3D-printed surgical solutions at scale in a matter of minutes, all while streamlining the process and providing surgical excellence. | $6M | Seed | Oct 29, 2025 |  |
| REE Automotive | REE is an automotive technology leader creating the cornerstone for tomorrow's zero-emission vehicles. REE’s mission is to empower global mobility companies to build any size or shape of electric or autonomous vehicle – from class 1 through class 6 – for any application and any target market. Our revolutionary, award-winning REEcornertechnology packs traditional vehicle drive components (steering, braking, suspension, powertrain and control) into the arch of the wheel, allowing for the industry's flattest EV platform. Unrestricted by legacy thinking, REE is a truly horizontal player, with technology applicable to the widest range of target markets and applications. Fully scalable and completely modular, REE offers multiple customer benefits including complete vehicle design freedom, more space and volume with the smallest footprint, lower TCO, faster development times, ADAS compatibility, reduced maintenance and global safety standard compliance. | $27M | Post-IPO Equity | Mar 18, 2025 |  |
| Arcuro Medical | Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013. |  | Series A | Jan 06, 2025 |  |
| REE Automotive | REE is an automotive technology leader creating the cornerstone for tomorrow's zero-emission vehicles. REE’s mission is to empower global mobility companies to build any size or shape of electric or autonomous vehicle – from class 1 through class 6 – for any application and any target market. Our revolutionary, award-winning REEcornertechnology packs traditional vehicle drive components (steering, braking, suspension, powertrain and control) into the arch of the wheel, allowing for the industry's flattest EV platform. Unrestricted by legacy thinking, REE is a truly horizontal player, with technology applicable to the widest range of target markets and applications. Fully scalable and completely modular, REE offers multiple customer benefits including complete vehicle design freedom, more space and volume with the smallest footprint, lower TCO, faster development times, ADAS compatibility, reduced maintenance and global safety standard compliance. | $45.4M | Post-IPO Equity | Sep 16, 2024 |  |
| APIGen | From connectors to entire backends, APIGen creates robust APIs from your prompts in minutes with GenAI.These APIs are complete with built-in testing, error handling, and security validations. Once created, users can download the complete codebases for these APIs and deploy them immediately to online servers—all accompanied by comprehensivedocumentation. | $500K | Pre-Seed | Jun 23, 2024 |  |
| NeuReality | NeuReality is a semiconductor start-up that designs AI-as-a-service infrastructure. It addresses the challenges posed by the growing deployment of AI in the cloud, edge, and fog systems. | $20M |  | Mar 19, 2024 |  |
| NeuReality | NeuReality is a semiconductor start-up that designs AI-as-a-service infrastructure. It addresses the challenges posed by the growing deployment of AI in the cloud, edge, and fog systems. | $20M | Series A | Mar 19, 2024 |  |
| NeuReality | NeuReality is a semiconductor start-up that designs AI-as-a-service infrastructure. It addresses the challenges posed by the growing deployment of AI in the cloud, edge, and fog systems. | $35M | Series A | Jun 20, 2022 |  |
| Stämm | Stämm is a biotechnology company dedicated to making biomanufacturing easy, scalable, sustainable, and repeatable. They are developing accessible, plug-and-play biomanufacturing solutions, allowing an automatized, continuous, and more efficient production of biologics and cell therapies. | $17M | Series A | Feb 28, 2022 |  |
| Stämm | Stämm is a biotechnology company dedicated to making biomanufacturing easy, scalable, sustainable, and repeatable. They are developing accessible, plug-and-play biomanufacturing solutions, allowing an automatized, continuous, and more efficient production of biologics and cell therapies. | $17M | Series A | Feb 28, 2022 |  |

10 of 32 investments shown.

## Co-investors
- [Cardumen Capital](https://shizune.co/investors/profile/cardumen-capital-sgeic-sa) — VC Fund, 5 deals together
- [M&G Investments](https://shizune.co/investors/profile/m-g-investments-2f25) — VC Fund, 5 deals together
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund, 4 deals together
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund, 4 deals together
- [Glory Ventures](https://shizune.co/investors/profile/glory-ventures) — VC Fund, 3 deals together
- [Samsung Ventures](https://shizune.co/investors/profile/samsung-ventures) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund
- [Entrée Capital](https://shizune.co/investors/profile/entree-capital) — VC Fund
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund

## Featured in investor lists
- [Artificial intelligence Investors in Israel](https://shizune.co/investors/artificial-intelligence-investors-israel)
- [Artificial intelligence VC Funds in Israel](https://shizune.co/investors/artificial-intelligence-vc-funds-israel)
- [Machine Learning Investors in Middle East](https://shizune.co/investors/machine-learning-investors-middle-east)
- [Machine Learning VC Funds in Middle East](https://shizune.co/investors/machine-learning-vc-funds-middle-east)
- [Medical Device Investors in Middle East](https://shizune.co/investors/medical-device-investors-middle-east)
- [Medical Device VC Funds in Middle East](https://shizune.co/investors/medical-device-vc-funds-middle-east)

## FAQ

### What does Varana Capital invest in?

Varana Capital invests primarily in Autonomous Vehicles, Artificial Intelligence and Automotive startups, most often at Funding Round and Seed stage. Most of the 32 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Varana Capital's check size?

Varana Capital typically joins rounds of $2.3M–$6M at Seed and $17M–$35M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Varana Capital participates in.

### How do I contact Varana Capital?

Public channels for Varana Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Varana Capital?

The team at Varana Capital includes Ezra Gardner (Co-Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co